Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Psychol Med

Retrieve available abstracts of 172 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LEMMERS-JANSEN ILJ, Fett AJ, Hanssen E, Veltman DJ, et al
    Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Psychol Med. 2018 Jun 13:1-11. doi: 10.1017/S003329171800140.
    PubMed     Text format     Abstract available


  2. HARTMANN JA, Nelson B, Ratheesh A, Treen D, et al
    At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.
    Psychol Med. 2018 Jun 4:1-13. doi: 10.1017/S0033291718001435.
    PubMed     Text format     Abstract available


    May 2018
  3. TAKAYANAGI Y, Sasabayashi D, Takahashi T, Komori Y, et al
    Altered brain gyrification in deficit and non-deficit schizophrenia.
    Psychol Med. 2018 May 9:1-8. doi: 10.1017/S0033291718001228.
    PubMed     Text format     Abstract available


  4. JESSEN K, Rostrup E, Mandl RCW, Nielsen MO, et al
    Cortical structures and their clinical correlates in antipsychotic-naive schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment.
    Psychol Med. 2018 May 8:1-10. doi: 10.1017/S0033291718001198.
    PubMed     Text format     Abstract available


  5. HALLGREN M, Skott M, Ekblom O, Firth J, et al
    Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001022.
    PubMed     Text format     Abstract available


  6. PALANIYAPPAN L, Hodgson O, Balain V, Iwabuchi S, et al
    Structural covariance and cortical reorganisation in schizophrenia: a MRI-based morphometric study.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001010.
    PubMed     Text format     Abstract available


  7. LUTGENS D, Joober R, Iyer S, Lepage M, et al
    Progress of negative symptoms over the initial 5 years of a first episode of psychosis - CORRIGENDUM.
    Psychol Med. 2018 May 2:1-3. doi: 10.1017/S0033291718000843.
    PubMed     Text format    


    April 2018
  8. MINOR KS, Willits JA, Marggraf MP, Jones MN, et al
    Measuring disorganized speech in schizophrenia: automated analysis explains variance in cognitive deficits beyond clinician-rated scales.
    Psychol Med. 2018 Apr 25:1-9. doi: 10.1017/S0033291718001046.
    PubMed     Text format     Abstract available


  9. DE JONG S, van Donkersgoed RJM, Timmerman ME, Aan Het Rot M, et al
    Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia.
    Psychol Med. 2018 Apr 25:1-11. doi: 10.1017/S0033291718000855.
    PubMed     Text format     Abstract available


  10. GUNNARSDOTTIR ED, Hallgren J, Hultman CM, McNeil TF, et al
    Risk of neurological, eye and ear disease in offspring to parents with schizophrenia or depression compared with offspring to healthy parents.
    Psychol Med. 2018 Apr 19:1-7. doi: 10.1017/S0033291718000338.
    PubMed     Text format     Abstract available


  11. KAPPELMANN N, Khandaker GM, Dal H, Stochl J, et al
    Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study.
    Psychol Med. 2018 Apr 6:1-8. doi: 10.1017/S0033291718000831.
    PubMed     Text format     Abstract available


    March 2018
  12. BARLATI S, Deste G, Gregorelli M, Vita A, et al
    Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates.
    Psychol Med. 2018 Mar 20:1-9. doi: 10.1017/S0033291718000600.
    PubMed     Text format     Abstract available


  13. LUTGENS D, Joober R, Iyer S, Lepage M, et al
    Progress of negative symptoms over the initial 5 years of a first episode of psychosis.
    Psychol Med. 2018 Mar 14:1-9. doi: 10.1017/S003329171800048.
    PubMed     Text format     Abstract available


  14. HEUVELMAN H, Nazroo J, Rai D
    Investigating ethnic variations in reporting of psychotic symptoms: a multiple-group confirmatory factor analysis of the Psychosis Screening Questionnaire.
    Psychol Med. 2018 Mar 12:1-9. doi: 10.1017/S0033291718000399.
    PubMed     Text format     Abstract available


  15. STABLEIN M, Storchak H, Ghinea D, Kraft D, et al
    Visual working memory encoding in schizophrenia and first-degree relatives: neurofunctional abnormalities and impaired consolidation.
    Psychol Med. 2018 Mar 9:1-9. doi: 10.1017/S003329171800051.
    PubMed     Text format     Abstract available


  16. BECK AT, Himelstein R, Bredemeier K, Silverstein SM, et al
    What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.
    Psychol Med. 2018 Mar 4:1-10. doi: 10.1017/S0033291718000442.
    PubMed     Text format     Abstract available


  17. ESCOTT-PRICE V, Smith DJ, Kendall K, Ward J, et al
    Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort.
    Psychol Med. 2018 Mar 4:1-6. doi: 10.1017/S0033291718000454.
    PubMed     Text format     Abstract available


    February 2018
  18. FERNANDEZ-EGEA E, Worbe Y, Bernardo M, Robbins TW, et al
    Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.
    Psychol Med. 2018 Feb 19:1-8. doi: 10.1017/S003329171800017.
    PubMed     Text format     Abstract available


  19. FERRI J, Ford JM, Roach BJ, Turner JA, et al
    Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.
    Psychol Med. 2018 Feb 15:1-8. doi: 10.1017/S003329171800003.
    PubMed     Text format     Abstract available


  20. VANES LD, Mouchlianitis E, Collier T, Averbeck BB, et al
    Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.
    Psychol Med. 2018 Feb 14:1-10. doi: 10.1017/S0033291718000041.
    PubMed     Text format     Abstract available


  21. BORA E, Akdede BB, Alptekin K
    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis - CORRIGENDUM.
    Psychol Med. 2018 Feb 8:1. doi: 10.1017/S0033291717003932.
    PubMed     Text format    


    January 2018
  22. VISSER KF, Esfahlani FZ, Sayama H, Strauss GP, et al
    An ecological momentary assessment evaluation of emotion regulation abnormalities in schizophrenia.
    Psychol Med. 2018 Jan 24:1-9. doi: 10.1017/S0033291717003865.
    PubMed     Text format     Abstract available


  23. PADULA MC, Schaer M, Armando M, Sandini C, et al
    Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
    Psychol Med. 2018 Jan 17:1-9. doi: 10.1017/S0033291717003920.
    PubMed     Text format     Abstract available


  24. ZWICKER A, Denovan-Wright EM, Uher R
    Gene-environment interplay in the etiology of psychosis.
    Psychol Med. 2018 Jan 15:1-12. doi: 10.1017/S003329171700383.
    PubMed     Text format     Abstract available


  25. BALLESTEROS A, Sanchez-Torres AM, Lopez-Ilundain JM, Cabrera B, et al
    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Psychol Med. 2018 Jan 14:1-10. doi: 10.1017/S0033291717003774.
    PubMed     Text format     Abstract available


    December 2017
  26. KILIAN S, Asmal L, Chiliza B, Olivier MR, et al
    Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition.
    Psychol Med. 2017 Dec 22:1-8. doi: 10.1017/S0033291717003671.
    PubMed     Text format     Abstract available


  27. RIGLIN L, Collishaw S, Richards A, Thapar AK, et al
    The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age.
    Psychol Med. 2017 Dec 14:1-6. doi: 10.1017/S0033291717003634.
    PubMed     Text format     Abstract available


  28. RANNING A, Laursen T, Agerbo E, Thorup A, et al
    School performance from primary education in the adolescent offspring of parents with schizophrenia and bipolar disorder- a national, register-based study.
    Psychol Med. 2017 Dec 14:1-8. doi: 10.1017/S0033291717003518.
    PubMed     Text format     Abstract available


  29. SILVERSTEIN SM, Paterno D, Cherneski L, Green S, et al
    Optical coherence tomography indices of structural retinal pathology in schizophrenia.
    Psychol Med. 2017 Dec 13:1-11. doi: 10.1017/S0033291717003555.
    PubMed     Text format     Abstract available


  30. HUFNER K, Brugger H, Kuster E, Dunsser F, et al
    Isolated psychosis during exposure to very high and extreme altitude - characterisation of a new medical entity.
    Psychol Med. 2017 Dec 5:1-8. doi: 10.1017/S0033291717003397.
    PubMed     Text format     Abstract available


    November 2017
  31. OKRUSZEK L, Wordecha M, Jarkiewicz M, Kossowski B, et al
    Brain correlates of recognition of communicative interactions from biological motion in schizophrenia.
    Psychol Med. 2017 Nov 27:1-10. doi: 10.1017/S0033291717003385.
    PubMed     Text format     Abstract available


  32. ZHANG T, Xu L, Tang Y, Cui H, et al
    Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Psychol Med. 2017 Nov 27:1-8. doi: 10.1017/S0033291717002707.
    PubMed     Text format     Abstract available


  33. ALLOTT K, Fraguas D, Bartholomeusz CF, Diaz-Caneja CM, et al
    Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.
    Psychol Med. 2017 Nov 27:1-18. doi: 10.1017/S0033291717003002.
    PubMed     Text format     Abstract available


  34. BLAKEY R, Ranlund S, Zartaloudi E, Cahn W, et al
    Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.
    Psychol Med. 2017 Nov 2:1-20. doi: 10.1017/S0033291717002860.
    PubMed     Text format     Abstract available


    October 2017
  35. ZOGHBI AW, Lieberman JA
    Alive but not well: the limited validity but continued utility of the concept of schizophrenia.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717001969.
    PubMed     Text format     Abstract available


  36. KAHN RS
    Why the concept of schizophrenia is still alive and kicking.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717002069.
    PubMed     Text format    


  37. NEILSON E, Bois C, Clarke TK, Hall L, et al
    Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.
    Psychol Med. 2017 Oct 25:1-11. doi: 10.1017/S0033291717003087.
    PubMed     Text format     Abstract available


  38. MUCCI A, Galderisi S, Green MF, Nuechterlein K, et al
    Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Psychol Med. 2017 Oct 11:1-10. doi: 10.1017/S0033291717002902.
    PubMed     Text format     Abstract available


  39. XIE DJ, Lui SSY, Geng FL, Yang ZY, et al
    Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals.
    Psychol Med. 2017 Oct 11:1-13. doi: 10.1017/S0033291717002926.
    PubMed     Text format     Abstract available


  40. AAS M, Melle I, Bettella F, Djurovic S, et al
    Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Psychol Med. 2017 Oct 2:1-7. doi: 10.1017/S0033291717001209.
    PubMed     Text format     Abstract available


    September 2017
  41. LU Y, Pouget JG, Andreassen OA, Djurovic S, et al
    Genetic risk scores and family history as predictors of schizophrenia in Nordic registers.
    Psychol Med. 2017 Sep 25:1-9. doi: 10.1017/S0033291717002665.
    PubMed     Text format     Abstract available


  42. DONOHOE G, Dillon R, Hargreaves A, Mothersill O, et al
    Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Psychol Med. 2017 Sep 21:1-14. doi: 10.1017/S0033291717001982.
    PubMed     Text format     Abstract available


  43. GAUGHRAN F, Lally J, Beck K, McCormack R, et al
    Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
    Psychol Med. 2017 Sep 18:1-9. doi: 10.1017/S0033291717002689.
    PubMed     Text format     Abstract available


  44. TIN LNW, Lui SSY, Ho KKY, Hung KSY, et al
    High-functioning autism patients share similar but more severe impairments in verbal theory of mind than schizophrenia patients.
    Psychol Med. 2017 Sep 18:1-12. doi: 10.1017/S0033291717002690.
    PubMed     Text format     Abstract available


  45. CULBRETH AJ, Moran EK, Barch DM
    Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms?
    Psychol Med. 2017 Sep 11:1-16. doi: 10.1017/S0033291717002525.
    PubMed     Text format     Abstract available


  46. SCHULTZE-LUTTER F, Michel C, Ruhrmann S, Schimmelmann BG, et al
    Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
    Psychol Med. 2017 Sep 11:1-15. doi: 10.1017/S0033291717002586.
    PubMed     Text format     Abstract available


  47. REEDER C, Huddy V, Cella M, Taylor R, et al
    A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.
    Psychol Med. 2017 Sep 4:1-11. doi: 10.1017/S0033291717001234.
    PubMed     Text format     Abstract available


    August 2017
  48. CURTIS D, Derks EM
    Letter to the Editor: Schizophrenia does not represent the extreme of a normally distributed trait.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002422.
    PubMed     Text format    


  49. BORA E
    Letter to the Editor: The half-alive concept of schizophrenia is still better than the spectrum of everything.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002446.
    PubMed     Text format    


  50. LEROY A, Petyt G, Pignon B, Vaiva G, et al
    Research Letter: Auto-activation deficit in schizophrenia: a case report.
    Psychol Med. 2017 Aug 24:1-3. doi: 10.1017/S0033291717002252.
    PubMed     Text format    


  51. DEGNAN A, Baker S, Edge D, Nottidge W, et al
    The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Aug 23:1-14. doi: 10.1017/S0033291717002264.
    PubMed     Text format     Abstract available


  52. SERPA MH, Doshi J, Erus G, Chaim-Avancini TM, et al
    State-dependent microstructural white matter changes in drug-naive patients with first-episode psychosis.
    Psychol Med. 2017 Aug 22:1-15. doi: 10.1017/S0033291717001015.
    PubMed     Text format     Abstract available


  53. DIMITRAKOPOULOS S, Vitoratou S, Mougiakos T, Bogeas N, et al
    Steinberg and Durell (1968) revisited: increased rates of First Episode Psychosis following military induction in Greek Army Recruits.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002276.
    PubMed     Text format     Abstract available


  54. BOUSMAN CA, Cropley V, Klauser P, Hess JL, et al
    Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002173.
    PubMed     Text format     Abstract available


  55. CURTIS D
    Association between smoking and psychosis may be mediated by maternal smoking during pregnancy.
    Psychol Med. 2017 Aug 14:1. doi: 10.1017/S0033291717002240.
    PubMed     Text format    


  56. HUANG X, Fox KR, Ribeiro JD, Franklin JC, et al
    Psychosis as a risk factor for suicidal thoughts and behaviors: a meta-analysis of longitudinal studies.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002136.
    PubMed     Text format     Abstract available


  57. REICHERT A, Jacobs R
    Socioeconomic inequalities in duration of untreated psychosis: evidence from administrative data in England.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002197.
    PubMed     Text format     Abstract available


    July 2017
  58. RUS-CALAFELL M, Garety P, Sason E, Craig TJK, et al
    Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness.
    Psychol Med. 2017 Jul 24:1-30. doi: 10.1017/S0033291717001945.
    PubMed     Text format     Abstract available


  59. MOLLON J, Reichenberg A
    Cognitive development prior to onset of psychosis.
    Psychol Med. 2017 Jul 24:1-12. doi: 10.1017/S0033291717001970.
    PubMed     Text format     Abstract available


  60. DREIER JW, Berg-Beckhoff G, Andersen AMN, Susser E, et al
    Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort.
    Psychol Med. 2017 Jul 24:1-11. doi: 10.1017/S0033291717001805.
    PubMed     Text format     Abstract available


  61. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis - CORRIGENDUM.
    Psychol Med. 2017 Jul 17:1. doi: 10.1017/S0033291717001866.
    PubMed     Text format    


  62. JEPSEN JRM, Rydkjaer J, Fagerlund B, Pagsberg AK, et al
    Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder.
    Psychol Med. 2017 Jul 17:1-13. doi: 10.1017/S0033291717001921.
    PubMed     Text format     Abstract available


  63. GULOKSUZ S, van Os J
    The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum.
    Psychol Med. 2017 Jul 10:1-16. doi: 10.1017/S0033291717001775.
    PubMed     Text format     Abstract available


    June 2017
  64. PAKSARIAN D, Trabjerg BB, Merikangas KR, Mors O, et al
    The role of genetic liability in the association of urbanicity at birth and during upbringing with schizophrenia in Denmark.
    Psychol Med. 2017 Jun 29:1-10. doi: 10.1017/S0033291717001696.
    PubMed     Text format     Abstract available


  65. CUI Y, Liu B, Song M, Lipnicki DM, et al
    Auditory verbal hallucinations are related to cortical thinning in the left middle temporal gyrus of patients with schizophrenia.
    Psychol Med. 2017 Jun 19:1-8. doi: 10.1017/S0033291717001520.
    PubMed     Text format     Abstract available


  66. BORA E, Ozerdem A
    Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.
    Psychol Med. 2017 Jun 6:1-14. doi: 10.1017/S0033291717001490.
    PubMed     Text format     Abstract available


    May 2017
  67. WALTON E, Hibar DP, van Erp TGM, Potkin SG, et al
    Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.
    Psychol Med. 2017 May 26:1-13. doi: 10.1017/S0033291717001283.
    PubMed     Text format     Abstract available


  68. ZHENG W, Li XH, Yang XH, Cai DB, et al
    Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Psychol Med. 2017 May 22:1-10. doi: 10.1017/S0033291717001271.
    PubMed     Text format     Abstract available


  69. DI BIASE MA, Cropley VL, Baune BT, Olver J, et al
    White matter connectivity disruptions in early and chronic schizophrenia.
    Psychol Med. 2017 May 22:1-14. doi: 10.1017/S0033291717001313.
    PubMed     Text format     Abstract available


  70. MORITZ S, Klein JP, Desler T, Lill H, et al
    Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
    Psychol Med. 2017 May 9:1-11. doi: 10.1017/S0033291717000939.
    PubMed     Text format     Abstract available


  71. BORA E, Binnur Akdede B, Alptekin K
    Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis.
    Psychol Med. 2017 May 4:1-14. doi: 10.1017/S0033291717000952.
    PubMed     Text format     Abstract available


  72. KRAKAUER K, Ebdrup BH, Glenthoj BY, Raghava JM, et al
    Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.
    Psychol Med. 2017 May 3:1-19. doi: 10.1017/S0033291717001210.
    PubMed     Text format     Abstract available


  73. ALDERSON HL, Semple DM, Blayney C, Queirazza F, et al
    Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study.
    Psychol Med. 2017 May 3:1-8. doi: 10.1017/S0033291717001118.
    PubMed     Text format     Abstract available


  74. LEES J, Michalopoulou PG, Lewis SW, Preston S, et al
    Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Psychol Med. 2017 May 3:1-11. doi: 10.1017/S0033291717000885.
    PubMed     Text format     Abstract available


    April 2017
  75. ORANJE B, Aggernaes B, Rasmussen H, Ebdrup BH, et al
    Selective attention and mismatch negativity in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717000599.
    PubMed     Text format     Abstract available


  76. PAN YJ, Yeh LL, Chan HY, Chang CK, et al
    Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717001040.
    PubMed     Text format     Abstract available


  77. SPENCER BWJ, Shields G, Gergel T, Hotopf M, et al
    Diversity or disarray? A systematic review of decision-making capacity for treatment and research in schizophrenia and other non-affective psychoses.
    Psychol Med. 2017 Apr 26:1-17. doi: 10.1017/S0033291717000502.
    PubMed     Text format     Abstract available


  78. PARELLADA M, Pina-Camacho L, Moreno C, Aleman Y, et al
    Insular pathology in young people with high-functioning autism and first-episode psychosis.
    Psychol Med. 2017 Apr 24:1-11. doi: 10.1017/S0033291717000988.
    PubMed     Text format     Abstract available


  79. OUELLET-PLAMONDON C, Abdel-Baki A, Salvat E, Potvin S, et al
    Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Psychol Med. 2017 Apr 20:1-11. doi: 10.1017/S0033291717000976.
    PubMed     Text format     Abstract available


  80. VERMEULEN J, van Rooijen G, Doedens P, Numminen E, et al
    Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.
    Psychol Med. 2017 Apr 11:1-12. doi: 10.1017/S0033291717000873.
    PubMed     Text format     Abstract available


  81. DEMJAHA A, Lappin JM, Stahl D, Patel MX, et al
    Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
    Psychol Med. 2017 Apr 11:1-9. doi: 10.1017/S0033291717000435.
    PubMed     Text format     Abstract available


  82. KNAPP F, Viechtbauer W, Leonhart R, Nitschke K, et al
    Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables.
    Psychol Med. 2017 Apr 7:1-15. doi: 10.1017/S0033291717000459.
    PubMed     Text format     Abstract available


  83. CHIEN WT, Bressington D, Yip A, Karatzias T, et al
    An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia.
    Psychol Med. 2017 Apr 4:1-16. doi: 10.1017/S0033291717000526.
    PubMed     Text format     Abstract available


    March 2017
  84. EMSLEY R, Asmal L, du Plessis S, Chiliza B, et al
    Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
    Psychol Med. 2017 Mar 28:1-10. doi: 10.1017/S0033291717000642.
    PubMed     Text format     Abstract available


  85. BRUCATO G, Masucci MD, Arndt LY, Ben-David S, et al
    Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Psychol Med. 2017 Mar 2:1-13. doi: 10.1017/S0033291717000319.
    PubMed     Text format     Abstract available


  86. TEMPELAAR WM, Termorshuizen F, MacCabe JH, Boks MP, et al
    Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in The Netherlands.
    Psychol Med. 2017;47:776-784.
    PubMed     Text format     Abstract available


  87. AAS M, Kauppi K, Brandt CL, Tesli M, et al
    Childhood trauma is associated with increased brain responses to emotionally negative as compared with positive faces in patients with psychotic disorders.
    Psychol Med. 2017;47:669-679.
    PubMed     Text format     Abstract available


    February 2017
  88. VAN RHEENEN TE, Lewandowski KE, Tan EJ, Ospina LH, et al
    Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.
    Psychol Med. 2017 Feb 28:1-17. doi: 10.1017/S0033291717000307.
    PubMed     Text format     Abstract available


  89. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Feb 16:1-13. doi: 10.1017/S0033291717000022.
    PubMed     Text format     Abstract available


  90. GRONHOLM PC, Thornicroft G, Laurens KR, Evans-Lacko S, et al
    Mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis: a systematic review.
    Psychol Med. 2017 Feb 15:1-13. doi: 10.1017/S0033291717000344.
    PubMed     Text format     Abstract available


  91. RHINDRESS K, Robinson DG, Gallego JA, Wellington R, et al
    Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
    Psychol Med. 2017 Feb 14:1-13. doi: 10.1017/S0033291717000137.
    PubMed     Text format     Abstract available


  92. XU Y, Qin W, Zhuo C, Xu L, et al
    Selective functional disconnection of the orbitofrontal subregions in schizophrenia.
    Psychol Med. 2017 Feb 10:1-10. doi: 10.1017/S0033291717000101.
    PubMed     Text format     Abstract available


  93. NIELSEN SM, Toftdahl NG, Nordentoft M, Hjorthoj C, et al
    Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Psychol Med. 2017 Feb 7:1-10. doi: 10.1017/S0033291717000162.
    PubMed     Text format     Abstract available


  94. OCHOA S, Lopez-Carrilero R, Barrigon ML, Pousa E, et al
    Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Psychol Med. 2017 Feb 7:1-12. doi: 10.1017/S0033291716003421.
    PubMed     Text format     Abstract available


    January 2017
  95. STONE J, Koychev I, Reilly T, McGuire P, et al
    Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2017 Jan 23:1. doi: 10.1017/S0033291716003470.
    PubMed     Text format    


  96. WOOLLEY JD, Chuang B, Fussell C, Scherer S, et al
    Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.
    Psychol Med. 2017 Jan 16:1-12. doi: 10.1017/S0033291716003433.
    PubMed     Text format     Abstract available


  97. STUDERUS E, Ramyead A, Riecher-Rossler A
    Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting.
    Psychol Med. 2017 Jan 16:1-16. doi: 10.1017/S0033291716003494.
    PubMed     Text format     Abstract available


  98. IWABUCHI SJ, Palaniyappan L
    Abnormalities in the effective connectivity of visuothalamic circuitry in schizophrenia.
    Psychol Med. 2017 Jan 12:1-11. doi: 10.1017/S0033291716003469.
    PubMed     Text format     Abstract available


    December 2016
  99. BORA E, Akdede BB, Alptekin K
    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Psychol Med. 2016 Dec 29:1-11. doi: 10.1017/S0033291716003366.
    PubMed     Text format     Abstract available


  100. LIU M, Malone SM, Vaidyanathan U, Keller MC, et al
    Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  101. MAIA-DE-OLIVEIRA JP, Baker GB, Dursun SM, Hallak JE, et al
    Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2016.
    PubMed     Text format    


  102. GAGE SH, Jones HJ, Burgess S, Bowden J, et al
    Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  103. STILO SA, Gayer-Anderson C, Beards S, Hubbard K, et al
    Further evidence of a cumulative effect of social disadvantage on risk of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    November 2016
  104. WU C, Zheng Y, Li J, Wu H, et al
    Brain substrates underlying auditory speech priming in healthy listeners and listeners with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  105. RAPADO-CASTRO M, Dodd S, Bush AI, Malhi GS, et al
    Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  106. CHANG WC, Kwong VW, Hui CL, Chan SK, et al
    Relationship of amotivation to neurocognition, self-efficacy and functioning in first-episode psychosis: a structural equation modeling approach.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  107. KLAAS HS, Clemence A, Marion-Veyron R, Antonietti JP, et al
    Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  108. LANGE EH, Nerland S, Jorgensen KN, Morch-Johnsen L, et al
    Alcohol use is associated with thinner cerebral cortex and larger ventricles in schizophrenia, bipolar disorder and healthy controls.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  109. MCHUGH MJ, McGorry PD, Yung AR, Lin A, et al
    Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  110. RYDKJAER J, Mollegaard Jepsen JR, Pagsberg AK, Fagerlund B, et al
    Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  111. SHAH C, Zhang W, Xiao Y, Yao L, et al
    Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  112. RIKANDI E, Pamilo S, Mantyla T, Suvisaari J, et al
    Precuneus functioning differentiates first-episode psychosis patients during the fantasy movie Alice in Wonderland.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  113. VEERMAN SR, Schulte PF, Deijen JB, de Haan L, et al
    Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  114. PRUESSNER M, Bechard-Evans L, Pira S, Joober R, et al
    Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  115. SCHMIDT A, Antoniades M, Allen P, Egerton A, et al
    Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  116. ROCCA P, Galderisi S, Rossi A, Bertolino A, et al
    Social cognition in people with schizophrenia: a cluster-analytic approach.
    Psychol Med. 2016;46:2717-29.
    PubMed     Text format     Abstract available


    September 2016
  117. STONE JM, Morrison PD, Koychev I, Gao F, et al
    The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  118. STEEL C, Hardy A, Smith B, Wykes T, et al
    Cognitive-behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  119. FRAJO-APOR B, Kemmler G, Pardeller S, Plass T, et al
    Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  120. VELING W, Counotte J, Pot-Kolder R, van Os J, et al
    Childhood trauma, psychosis liability and social stress reactivity: a virtual reality study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  121. LALLY J, Ajnakina O, Di Forti M, Trotta A, et al
    Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  122. FISZDON JM, Choi KH, Bell MD, Choi J, et al
    Cognitive remediation for individuals with psychosis: efficacy and mechanisms of treatment effects.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  123. CHEN DC, Du XD, Yin GZ, Yang KB, et al
    Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  124. O'REILLY K, O'Connell P, Donohoe G, Coyle C, et al
    Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  125. RINGEN PA, Nesvag R, Helle S, Lagerberg TV, et al
    Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  126. HODGINS S, Larm P, Westerman J
    Individuals developing schizophrenia are hidden among adolescent substance misusers.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  127. PERALTA V, Cuesta MJ
    Delusional disorder and schizophrenia: a comparative study across multiple domains.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  128. RENTZSCH J, Koller K, Kronenberg G
    Letter to the Editor: Disentangling cause and effect in the relationship between cannabis and psychosis: are we there yet?
    Psychol Med. 2016.
    PubMed     Text format    


  129. MIKOLAS P, Melicher T, Skoch A, Matejka M, et al
    Connectivity of the anterior insula differentiates participants with first-episode schizophrenia spectrum disorders from controls: a machine-learning study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  130. RIMVALL MK, Clemmensen L, Munkholm A, Rask CU, et al
    Introducing the White Noise task in childhood: associations between speech illusions and psychosis vulnerability.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  131. REININGHAUS U, Gayer-Anderson C, Valmaggia L, Kempton MJ, et al
    Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  132. WANG C, Ji F, Hong Z, Poh JS, et al
    Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  133. FINEBERG SK, Leavitt J, Deutsch-Link S, Dealy S, et al
    Self-reference in psychosis and depression: a language marker of illness.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  134. HU M, Zong X, Zheng J, Mann JJ, et al
    Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  135. HUI CL, Li YK, Li AW, Lee EH, et al
    Visual working memory deterioration preceding relapse in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  136. DE BONT PA, van den Berg DP, van der Vleugel BM, de Roos C, et al
    Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  137. BERGINK V, Laursen TM, Johannsen BM, Kushner SA, et al
    Letter to the Editor: Postpartum psychosis and pre-eclamptic toxaemia: a reply.
    Psychol Med. 2016.
    PubMed     Text format    


  138. CHEN LJ, Steptoe A, Chung MS, Ku PW, et al
    Association between actigraphy-derived physical activity and cognitive performance in patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  139. BROCKINGTON I
    Letter to the Editor Postpartum psychosis and pre-eclamptic toxaemia.
    Psychol Med. 2016.
    PubMed     Text format    


  140. JUNG E, Wiesjahn M, Wendt H, Bock T, et al
    Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  141. HARING L, Muursepp A, Mottus R, Ilves P, et al
    Cortical thickness and surface area correlates with cognitive dysfunction among first-episode psychosis patients.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  142. GUO S, Palaniyappan L, Liddle PF, Feng J, et al
    Dynamic cerebral reorganization in the pathophysiology of schizophrenia: a MRI-derived cortical thickness study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  143. BAKKER G, Caan MW, Schluter RS, Bloemen OJ, et al
    Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  144. LEE EH, Hui CL, Chang WC, Chan SK, et al
    Letter to the Editor: Comparison of cognitive functions, pre-morbid conditions and clinical characteristics between brief psychotic disorder and schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format    


  145. O'DONOGHUE B, Lyne JP, Renwick L, Lane A, et al
    Neighbourhood characteristics and the incidence of first-episode psychosis and duration of untreated psychosis.
    Psychol Med. 2016;46:1367-78.
    PubMed     Text format     Abstract available


    April 2016
  146. CABRERA B, Bioque M, Penades R, Gonzalez-Pinto A, et al
    Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  147. KIMHY D, Gill KE, Brucato G, Vakhrusheva J, et al
    The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  148. JORGENSEN KN, Nerland S, Norbom LB, Doan NT, et al
    Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  149. VEERMAN SR, Schulte PF, Smith JD, de Haan L, et al
    Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  150. CROSSLEY NA, Fox PT, Bullmore ET
    Meta-connectomics: human brain network and connectivity meta-analyses.
    Psychol Med. 2016;46:897-907.
    PubMed     Text format     Abstract available


    March 2016
  151. MORGAN C, John S, Esan O, Hibben M, et al
    The incidence of psychoses in diverse settings, INTREPID (2): a feasibility study in India, Nigeria, and Trinidad.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  152. VAN OMMEN MM, van Beilen M, Cornelissen FW, Smid HG, et al
    The prevalence of visual hallucinations in non-affective psychosis, and the role of perception and attention.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  153. ISING HK, Ruhrmann S, Burger NA, Rietdijk J, et al
    Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  154. WANG Q, Cheng W, Li M, Ren H, et al
    The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  155. RIGUCCI S, Marques TR, Di Forti M, Taylor H, et al
    Effect of high-potency cannabis on corpus callosum microstructure.
    Psychol Med. 2016;46:841-54.
    PubMed     Text format     Abstract available


    February 2016
  156. FORTGANG RG, Hultman CM, van Erp TG, Cannon TD, et al
    Multidimensional assessment of impulsivity in schizophrenia, bipolar disorder, and major depressive disorder: testing for shared endophenotypes.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  157. FETT AJ, Shergill SS, Korver-Nieberg N, Yakub F, et al
    Learning to trust: trust and attachment in early psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  158. PU W, Luo Q, Palaniyappan L, Xue Z, et al
    Failed cooperative, but not competitive, interaction between large-scale brain networks impairs working memory in schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  159. BEGEMANN MJ, Daalman K, Heringa SM, Schutte MJ, et al
    Letter to the Editor: Childhood trauma as a risk factor for psychosis: the confounding role of cognitive functioning.
    Psychol Med. 2015.
    PubMed     Text format    


  160. HUI CL, Lee EH, Chang WC, Chan SK, et al
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015) - a reply.
    Psychol Med. 2015.
    PubMed     Text format    


  161. PERALTA V, Cuesta MJ
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015).
    Psychol Med. 2015.
    PubMed     Text format    


  162. GERSTENBERG M, Theodoridou A, Traber-Walker N, Franscini M, et al
    Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  163. FONSECA-PEDRERO E, Debbane M, Schneider M, Badoud D, et al
    Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  164. BIANCONI F, Bonomo M, Marconi A, Kolliakou A, et al
    Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  165. BARKER V, Bois C, Johnstone EC, Owens DG, et al
    Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  166. VREEKER A, Boks MP, Abramovic L, Verkooijen S, et al
    High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  167. LEVINE SZ, Levav I, Goldberg Y, Pugachova I, et al
    Exposure to genocide and the risk of schizophrenia: a population-based study.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  168. KRAAN T, Velthorst E, Koenders L, Zwaart K, et al
    Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  169. VELING W, Susser E, Selten JP, Hoek HW, et al
    Social disorganization of neighborhoods and incidence of psychotic disorders: a 7-year first-contact incidence study.
    Psychol Med. 2015;45:1789-98.
    PubMed     Text format     Abstract available


    May 2015
  170. WICKHAM S, Sitko K, Bentall RP
    Insecure attachment is associated with paranoia but not hallucinations in psychotic patients: the mediating role of negative self-esteem.
    Psychol Med. 2015;45:1495-507.
    PubMed     Text format     Abstract available


    April 2015
  171. VELIKONJA T, Fisher HL, Mason O, Johnson S, et al
    Childhood trauma and schizotypy: a systematic literature review.
    Psychol Med. 2015;45:947-63.
    PubMed     Text format     Abstract available


  172. FETT AK, Shergill SS, Krabbendam L
    Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction.
    Psychol Med. 2015;45:1145-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: